EMEA-002893- PIP01-20-M01
Table of contents
Key facts
Invented name |
|
Active substance |
mRNA that encodes for the pre-fusion stabilized spike glycoprotein of SARS-CoV-2 (mRNA-1273)
|
Therapeutic area |
|
Decision number |
P/0444/2021
|
PIP number |
EMEA-002893- PIP01-20-M01
|
Pharmaceutical form(s) |
Dispersion for injection
|
Condition(s) / indication(s) |
Prevention of Coronavirus disease 2019 (COVID-19)
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
MODERNA BIOTECH SPAIN, S.L.
E-mail: Nadia.Assenova@modernatx.com Tel. +41 794746697 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|